Clinical Trials Insight: 700052784

Trial Profile

Clinical Trials Insight: 700052784

Phase of Trial: Phase I

Latest Information Update: 19 Jun 2009

At a glance

  • Drugs Influenza virus delta-NS1 vaccine (Primary)
  • Indications Influenza A virus H5N1 subtype
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors AVIR Green Hills Biotechnology
  • Most Recent Events

    No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top